Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Different types of PCOS need specific diagnosis methods and treatments.

Most pregnant women experience skin changes, especially increased pigmentation.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Thyroid function may influence hair loss after COVID-19.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.